Navigation Links
Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer
Date:12/21/2007

England Journal of Medicine with a similar outcome. These compelling results from two large well-controlled studies are expected to lead to widespread adoption of CT colonography (also known as virtual colonoscopy) as routine primary screening for colorectal cancer.

All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward- looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.

For further information: Media enquiries:

MGT Capital Investments KCSA Worldwide

Alex van Klaveren Todd Fromer / Garth Russell

Tel: +1 646-257-2644 Tel: +1 212-896-1215 / 212-896-1250

alex@mgtci.com tfromer@kcsa.com / grussell@kcsa.com

http://www.mgtci.com


'/>"/>
SOURCE MGT Capital Investments, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. FRC Applauds New Ballot Initiative for Cures Without Cloning
3. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
4. New Initiative Has Shocking Effect: Thousands of Missourians with Abnormal Chromosome Structures Are Not Human
5. Cardinal Health Establishes $1 Million Grant Fund for Initiatives That Improve Quality, Safety of Patient Care
6. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
7. International Atomic Energy Agency and National Foundation for Cancer Research Launch Major Initiative to Improve Cancer Prevention and Treatments in Developing Countries
8. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
9. Statement from GPhA President and CEO Kathleen Jaeger on FDAs Generic Initiative
10. CCPM Issues Statement on FDAs GIVE Initiative
11. Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... BRUSSELS, December 14 , ... Lifestyles of,Women With Rheumatoid Arthritis in Seven Major Industrialized Countries ... living with rheumatoid arthritis say their disease, ... - Women living with rheumatoid arthritis find shopping ... writing cards and wrapping presents most, ...
(Date:12/11/2009)... (12/11/2009) Boston College researchers have observed the "hot ... time and successfully harvested the elusive charges using ultra-thin ... power efficiency, the authors report in the current online ... light is captured in solar cells, it generates free ... order to snare these charges, the electrons must reach ...
(Date:12/11/2009)... Dec. 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, ... announced the appointment of Dr. Alan Warrander to ... and Business Development. ,, "Dr. Warrander will be ... strategy for REOLYSIN(R)," said Dr. Brad Thompson, President ... on the design of a Phase 3 trial ...
(Date:12/10/2009)... The National Eye Institute (NEI), a division of the National ... Aciont Inc. to help fund its development of a non-invasive, ... , ... Salt Lake City, UT (PRWEB) ... division of the National Institutes of Health (NIH), awarded a ...
Breaking Biology Technology:Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4Elusive 'hot' electrons captured in ultra-thin solar cells 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3
... 25 Tengion Inc., a clinical stage regenerative medicine company focused ... Nichtberger, M.D., President and Chief Executive Officer of Tengion, will present ... 2, 2008 at 9:50 a.m. EST at The Palace Hotel in ... About Tengion , , ...
... /PRNewswire-Asia/ -- ScinoPharm, an active,pharmaceutical ingredient (API) specialist, ... entitled "Novel Crystal Forms of Irinotecan,Hydrochloride." The new ... and processes for their preparation as well as,pharmaceutical ... treating,metastatic carcinoma of the colon or rectum using ...
... Nov. 24 3SBio Inc. (Nasdaq: SSRX ... marketing biopharmaceutical products primarily in China,announced that Dr. Yingfei ... 20th Annual Health Care Conference in New York on ... The presentation will be ...
Other Biology Technology:ScinoPharm Granted US Patent for Novel Crystal Forms 2
(Date:12/14/2009)... you are spending the holidays with big Uncle Frank ... be better off with another family, spare a thought ... team from McMaster University and the University of New ... that lives in groups, members make strategic decisions about ... the current issue of Biology Letters . , ...
(Date:12/14/2009)... MODA Technology Partners, a global software ... product testing for the Pharmaceutical industry, today announced ... third generation mobile data acquisition platform. The latest ... automate their regulated manufacturing processes. ,, MODA ... Fully-Configurable Test Methods: Each test method ...
(Date:12/13/2009)... Conn.A team led by Yale University researchers has ... blood for the first time. Their findings, which ... of Nature Nanotechnology , could dramatically simplify ... and other diseases. , The teamled ... Engineering & Applied Science, and Tarek Fahmy, an ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Galil Medical Announces Establishment of Global Headquarters in Minneapolis MN 5093 1Galil Medical Announces Establishment of Global Headquarters in Minneapolis MN 5093 2Article Published in Expert Opinion on Biological Therapy Evaluates StemEx 28R 29 28carlecortemcel l 29 for Leukemia and Lymphoma 5089 1Article Published in Expert Opinion on Biological Therapy Evaluates StemEx 28R 29 28carlecortemcel l 29 for Leukemia and Lymphoma 5089 2Article Published in Expert Opinion on Biological Therapy Evaluates StemEx 28R 29 28carlecortemcel l 29 for Leukemia and Lymphoma 5089 3InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study 5085 1InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study 5085 2
... part of our daily vocabulary. We all know they,re part ... pastas. We know they have something to do with starches ... still a lot for science to learn about them. ... said Nikki Pohl, an Iowa State University associate professor of ...
... have made a major new advance in taking waste heat ... technology that can improve the energy efficiency of diesel engines, ... industry. , This heat-actuated cooling system, which will probably find ... applied to automobiles, factories or other places where waste heat ...
... Washington, D.C.April 1, 2009For the past several decades, evidence ... folate, offers protection against the development of certain common ... new avenues for public health interventions that have a ... an essential factor in DNA synthesis also means that ...
Other Biology News:Iowa State chemist synthesizes carbohydrates, launches startup company 2Breakthrough made in energy efficiency, use of waste heat 2Breakthrough made in energy efficiency, use of waste heat 3Health benefits, consequences of folic acid dependent on circumstances 2
...
Rabbit polyclonal to LCAT ( Abpromise for all tested applications). entrezGeneID: 3931 SwissProtID: P04180...
HAMP Immunogen: HAMP (AAH20612, 25 a.a. ~ 85 a.a) full length recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
... Nabeta2. The epitope specific for ... any other known proteins.,SPECIES REACTIVITIES: ... work on human because the ... (17/19 residues). Reactivity with other ...
Biology Products: